NIH Considers Action on Pay-to-Participate Trials: FDA raids stem cell clinics, charging questionable practices

    loading  Checking for direct PDF access through Ovid

Abstract

Recent action by federal authorities against stem cell clinics charged with questionable practices appear to validate concerns raised by bioethicists like Leigh Turner, PhD, who recently warned that some stem cell clinics are charging research subjects exorbitant fees for participation in experimental treatments marketed as clinical trials on ClinicalTrials.gov.

Related Topics

    loading  Loading Related Articles